Researchers discover promising new targets for treatment of fatty liver disease

Researchers have identified potential new drug targets for the prevention and treatment of non-alcoholic fatty liver disease (NAFLD). The new study, which was a collaborative effort between scientists in the Laboratory of Metabolism at CCR and Peking University, was published October 9, 2017, in Nature Medicine. Read more…

 

Shiv Grewal receives 2017 Indian National Science Academy Foreign Fellowship

Posted: Oct 17, 2017

Shiv Grewal, Ph.D., Chief of the Laboratory of Biochemistry and Molecular Biology, has been named an Indian National Science Academy (INSA) Foreign Fellow for his pioneering contributions on the role of epigenetic modifications in heterochromatin assembly and discovery of relation between heterochromatin assembly and RNAi. The INSA Foreign Fellowship is designated to scientists recognized as international leaders in their field. Dr. Grewal is one of four researchers to receive the 2017 fellowship.

Shiv Grewal receives 2017 Indian National Science Academy Foreign Fellowship

Former CCR fellow named a 2017 STAT Wunderkind

Posted: Oct 17, 2017

Daniel Webster, Ph.D., a former fellow at CCR, has been named a 2017 STAT Wunderkind for the development of “Mole Mapper” — an app that catalogs potentially cancerous moles and helps those at risk of skin cancer effectively communicate with researchers and clinicians. STAT News, a publication produced by Boston Globe Media, annually selects 26 young scientists as “wunderkinds” in recognition of their efforts to answer some of the biggest questions in medicine. According to STAT, “Over the past several months, a team of STAT editors and reporters pored through nearly 300 nominations from across North America. We didn’t set an age limit; we were on the hunt for the most impressive doctors and researchers on the cusp of launching their careers but not yet fully independent. Most were postdocs, fellows, and biopharma employees working with more senior scientists.” Dr. Webster currently works at Sage Bionetworks. 

Former CCR fellow named a 2017 STAT Wunderkind

Vassiliki Saloura appointed as Assistant Clinical Investigator

Posted: Oct 11, 2017

Vassiliki Saloura, M.D., has joined the Thoracic and Gastrointestinal Oncology Branch (TGIB) as an Assistant Clinical Investigator.  Dr. Saloura’s laboratory investigates the role of histone and non-histone protein methylation in tumor growth, therapy resistance and immunogenicity in squamous cell carcinoma of the aerodigestive tract. Learn more . . .

Vassiliki Saloura appointed as Assistant Clinical Investigator

Watching the action unfold: New cryo-EM images capture CRISPR’s interaction with target DNA

Posted: Oct 5, 2017

Using the Nobel-prize winning technique of cryo-EM, researchers led by CCR Senior Investigator Sriram Subramaniam, Ph.D., have captured a series of highly detailed images of a protein complex belonging to the CRISPR system that can be used by bacteria to recognize and destroy foreign DNA. The images reveal the molecule’s form before and after its interaction with DNA and help illuminate both how the complex functions and how it can be blocked. Read more... 

Watching the action unfold: New cryo-EM images capture CRISPR’s interaction with target DNA

CCR Celebrates National Postdoc Appreciation Week 2017

Posted: Oct 3, 2017

National Postdoc Appreciation Week took place Sept. 18-22, 2017, and the Center for Cancer Research (CCR) joined in to celebrate the work of our postdocs. The CCR offers basic and translational research opportunities for pre- and postdoctoral fellows with competitive stipends through the Cancer Research Training Award. Throughout the week, our postdocs shared their reasons for choosing CCR, and we highlighted some of our outstanding postdocs and why CCR is a premier training institution. To get a glimpse into why these postdocs chose CCR for their training, check out this Storify...

CCR Celebrates National Postdoc Appreciation Week 2017

Efsun Arda appointed as NIH Stadtman Investigator

Posted: Oct 2, 2017

H. Efsun Arda, Ph.D., has joined the Laboratory of Receptor Biology and Gene Expression (LRBGE) as a Stadtman tenure track investigator. Dr. Arda spearheaded the development of genomic and epigenetic analysis of primary pancreatic cells obtained from children and adult donors using single cell analysis.  Her research focuses on understanding the genomic information that governs development, differentiation and function of pancreatic cell lineages.  Learn more...
 

Efsun Arda appointed as NIH Stadtman Investigator

October is Breast Cancer Awareness Month

Posted: Oct 2, 2017

To recognize Breast Cancer Awareness Month this October, we are highlighting our researchers who are making discoveries in this field. Read more…

October is Breast Cancer Awareness Month

Recap: Lymphoma Twitter Chat for Blood Cancer Awareness and Childhood Cancer Awareness Month

Posted: Sep 27, 2017

On September 20, 2017, the National Cancer Institute co-hosted a Twitter chat with the Lymphoma Research Foundation for Blood Cancer Awareness and Childhood Cancer Awareness Month. Nirali Shah, M.D., of the Center for Cancer Research, and Nita Seibel, M.D., of the Division of Cancer Treatment and Diagnosis, offered their expertise to discuss lymphoma treatment and trials for children and young adults. This Storify recaps the Twitter chat.

Recap: Lymphoma Twitter Chat for Blood Cancer Awareness and Childhood Cancer Awareness Month

Douglas Lowy and Nirali Shah discuss advancements in cancer treatment at the second annual Chasing Cancer Summit

Posted: Sep 26, 2017

On Monday, September 18, 2017, the second annual Chasing Cancer Summit was held at the Washington Post headquarters in downtown Washington, D.C. The live event brought together a group of experts, including CCR’s Douglas Lowy, M.D., and Nirali Shah, M.D., for discussions on the latest developments in cancer detection and treatment.  Read more...

Douglas Lowy and Nirali Shah discuss advancements in cancer treatment at the second annual Chasing Cancer Summit

Nicholas Restifo awarded 2018 ASM Award in Clinical and Diagnostic Immunology

Posted: Sep 25, 2017

The American Society for Microbiology (ASM) has selected Nicholas Restifo, M.D., Senior Investigator in the Surgery Branch, to receive the 2018 ASM Award in Clinical and Diagnostic Immunology. The award recognizes scientists for their outstanding contributions to microbiology in service of science and the public. Learn more…

Nicholas Restifo awarded 2018 ASM Award in Clinical and Diagnostic Immunology

Pages